pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

TAG: Drug Discovery

Sep 6, 2023

Nimbus Therapeutics Secures $210M Private Financing to Advance Next Wave of Tech-Enabled Small Molecule Medicines

Jun 1, 2023

Switch Therapeutics Announces Formation of Scientific Advisory Board

May 10, 2023

AI Drug Discovery Company Insilico Medicine Offers Free Course on Target Identification

May 4, 2023

Head of Insilico Medicine’s Hong Kong RandD Center to Give Keynote on AI Drug Discovery at HKUST Big Data Institute

May 2, 2023

Alloy Therapeutics to Empower Drug Discovery of Lundbeck’s Biologics for Brain Health

Apr 26, 2023

Anima Biotech's Webinar Series: Exploring the Potential of mRNA Biology for Drug Discovery and Therapeutic Intervention

Apr 10, 2023

Anima Biotech to Present at the 4th Annual RNA-Targeting Small Molecule Drugs hosted by CHI as part of the 18th Annual Drug Discovery Event

Mar 29, 2023

Lucy Therapeutics Appoints Neuroscience Drug Discovery and Development Expert Christopher J. Winrow, Ph.D., as Chief Scientific Officer

Mar 27, 2023

Meliora Therapeutics Appoints Claudio Chuaqui, Ph.D., as Head of Drug Discovery

Mar 2, 2023

Antiverse Raises Funding and Demonstrates Therapeutic Antibody Identification With AI-driven Drug Discovery Platform

Feb 22, 2023

eureKARE co-founds EonBio to revolutionize drug discovery with pioneering cell-free technology on a chip

Feb 14, 2023

Delix Therapeutics Partners With Cellectricon, Expressive Neuroscience and Expands Science Team To Accelerate Drug Discovery and Translatability

Jan 5, 2023

Insilico Medicine launches 6th generation Intelligent Robotics Lab to further accelerate its AI-driven drug discovery

Jan 4, 2023

Ventus Therapeutics Nominates Potential First-in-Class cGAS Inhibitor VENT-03 as Inaugural Development Candidate in cGAS Franchise

Dec 14, 2022

Anima Biotech To Present And Participate In Panel Discussion At The 5th RNA Targeted Drug Discovery Summit

Dec 11, 2022

HitGen Announces Research Agreement with Nitrase Therapeutics Focused on DNA-Encoded Library Based Drug Discovery

Dec 8, 2022

NextRNA Therapeutics to Participate in Upcoming 5th Annual RNA-Targeted Drug Discovery Summit

Dec 8, 2022

Remix Therapeutics to Present at 5th Annual RNA-Targeted Drug Discovery Summit

Nov 29, 2022

Rewind Therapeutics Appoints Dr. Stephen Burbidge to its Management Team

Nov 21, 2022

Nona Biosciences Enters into HCAb Based Drug Discovery Collaboration Agreement with Dragonfly Therapeutics

Nov 14, 2022

Alice Zhang, CEO and Co-founder of Verge Genomics, Recognized Today by Both Fortune and Fierce Biotech as a Pioneer in AI-Driven Drug Discovery

Nov 8, 2022

Immune-Onc Therapeutics Appoints Two New Members to its Board of Directors

Nov 7, 2022

Maxwell Biosciences Names Two Biotech Leaders to Its Board of Directors

Oct 18, 2022

Avilar Therapeutics to Present New In Vivo Proof-of-Concept Data for ATAC Extracellular Protein Degraders at Upcoming Drug Discovery Conferences

Oct 17, 2022

Verge Genomics Appoints John Applegate as Chief Financial Officer

Oct 6, 2022

Rectify Pharmaceuticals Appoints Robert Hughes as Executive Vice President, Drug Discovery and Preclinical Development, and Xiaobing Li as Chief Development Officer

Aug 17, 2022

Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery

Aug 15, 2022

EpiAxis Therapeutics and Peptilogics Enter Strategic Drug Discovery Partnership

Jul 19, 2022

Propanc Biopharma Successfully Produces Synthetic Recombinant Trypsinogen Via POP1 Joint Research and Drug Discovery Program

Jul 13, 2022

Xilis Announces Series A Extension, Bringing Total Round to Over US$89 Million

Jul 12, 2022

Terray Therapeutics Expands Scientific Advisory Board to Advance AI-Driven Small Molecule Drug Discovery

Jul 12, 2022

Orion Biotechnology and Peptilogics Enter Strategic Research Collaboration to Enable AI-Driven Drug Discovery Against Undrugged GPCR Target

Jul 6, 2022

Nitrase Therapeutics Expands Leadership Team with Accomplished Drug Discovery and Development Executives

Jun 30, 2022

ROME Therapeutics Announces Publication of First Crystal Structure of a Human Endogenous Reverse Transcriptase in PNAS

Jun 28, 2022

Confo Therapeutics Awarded EUR 1.7M VLAIO Grant to Expand Application of ConfoBody Drug Discovery and Development Technology in Rare Diseases

Jun 28, 2022

Araris Biotech AG to Present at the H.C. Wainwright Preclinical Cancer Drug Discovery Virtual Conference

Jun 9, 2022

Alloy Therapeutics Ecosystem Offerings Go Intracellular Through Collaboration with Sudhir Agrawal in Genetic Medicines

Jun 2, 2022

ElevateBio Announces Jill M. Mooney, Ph.D., Joins as Senior Vice President of Research and Development

May 25, 2022

Excelra Partners with HotSpot Therapeutics to Enhance Allosteric Drug Discovery Efforts USA - English USA - English France - Français España - español Deutschland - Deutsch Brazil - Português Latin America - español

May 19, 2022

GigaGen Publishes Research Demonstrating the Potential of its Machine Learning Platform to Improve Antibody Drug Discovery and Development

May 17, 2022

Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR Targets for Drug Discovery

May 16, 2022

Avilar Therapeutics Announces Formation of Scientific Advisory Board With Leading Experts in Protein Degradation, Chemistry, Genetics, and Drug Discovery

May 3, 2022

Avilar Therapeutics Executives to be Featured Speakers on Advances in Protein Degradation at Upcoming Drug Discovery Conferences

Apr 14, 2022

BridGene Biosciences Announces Acceptance of Two Abstracts for Poster Presentations at Cambridge Health Institute's Inaugural Drug Discovery Chemistry Conference

Apr 14, 2022

Rheos Medicines Appoints Katerina Leftheris, Ph.D., as SVP of Drug Discovery and Nabil Uddin, Pharm.D., as VP of Strategy and Business Development

Apr 7, 2022

Rona Therapeutics Announces Completion of $33 Million Series A Financing to Advance Global Discovery and Development of RNA Therapeutics

Mar 29, 2022

IAMA Therapeutics Partners with the Italian Institute of Technology to Embark on Landmark Research on Neuroscience Drug Discovery

Mar 23, 2022

Cyclica and Arctoris to Expand Partnership to Advance Drug Discovery Programs for Alzheimer's Disease

Mar 21, 2022

Volastra Therapeutics Announces Drug Discovery Collaboration with Bristol Myers Squibb

Mar 10, 2022

Exscientia and University of Oxford Launch “Xcellomics” Program to Expedite Early-Stage Academic Research and Translate Novel Biology Into Future Drug Discovery

Mar 8, 2022

CODA Biotherapeutics Names Susan Catalano, Ph.D., as Chief Scientific Officer

Feb 22, 2022

Anima Biotech to Present at Hanson Wade 3rd Annual RAS/MAPK Pathway Targeted Drug Discovery Summit

Feb 17, 2022

Remix Therapeutics Enters Collaboration with Janssen to Advance Small Molecule Therapeutics Using REMaster Drug Discovery Platform to Modulate RNA Processing

Feb 15, 2022

IMIDomics, Inc. Announces Strategic Investment from Drug Discovery and Research Leader Evotec SE

Feb 15, 2022

Terray Therapeutics Launches with $60M to Deliver Premium Chemical Data at Unrivaled Scale, Unlocking the Potential of AI-Driven Small Molecule Drug Discovery

Feb 1, 2022

Cyclica Recruits Big Pharma Veteran Michael Palovich as Chief Science Officer to Advance Robust Drug Discovery Pipeline

Jan 19, 2022

Second Genome Appoints Joseph Dal Porto, Ph.D., as Chief Scientific Officer

Jan 19, 2022

XtalPi Partners with Excelra for GOSTAR to Enhance its Intelligent Digital Drug Discovery and Development platform USA - English Latin America - español Brazil - Português USA - English España - español USA - English

Jan 17, 2022

Neurimmune expands drug discovery collaboration with Ono Pharmaceutical in the field of neurodegenerative diseases

Jan 12, 2022

insitro Announces Leadership Team Expansion to Support Advancement of Machine Learning Enabled Drug Discovery and Development Efforts

Jan 9, 2022

Zymergen Announces Emerging Drug Discovery Business Enabled by One of the World’s Largest Metagenomics Databases and Proprietary Synthetic Biology Platform

Jan 7, 2022

Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered Medicines

Dec 16, 2021

Verge Genomics Secures $98 Million in New Financing

Dec 16, 2021

Antengene and XtalPi Announce AI-Driven RandD Collaboration

Dec 8, 2021

Artificial Intelligence (AI) In Drug Discovery Global Market Report 2021 Featuring IBM, Microsoft, Atomwise, Deep Genomics, Insilico Medicine, Benevolent AI, Exscientia, Cyclica, and BIOAGE - ResearchAndMarkets.com

Dec 6, 2021

Anima Biotech to Participate in RNA-Targeted Drug Discovery Summit

Dec 3, 2021

AI Drug Discovery and Design Global Market Insights 2021, Featuring Relay Therapeutics, Schrodinger, PathAI, Cellarity and Atomwise - ResearchAndMarkets.com

Nov 30, 2021

Confo Therapeutics Enters Collaborative Agreement with Regeneron

Nov 29, 2021

HotSpot Therapeutics Closes $100M Series C to Advance First-in-Class Allosteric Drug Discovery Platform to the Clinic

Nov 3, 2021

Model Medicines Raises $4.1 Million to Discover and Advance Therapeutics Using its AI Drug Discovery Platform

Nov 1, 2021

Muna Therapeutics Appoints Dr. Niels Plath as Chief Scientific Officer

Oct 27, 2021

XtalPi and Signet Expand AI Drug Discovery Collaboration to Novel Cancer Target

Oct 14, 2021

Exelixis and STORM Therapeutics Enter into Exclusive Collaboration and License Agreement to Discover and Develop Inhibitors of Novel RNA Modifying Enzymes

Sep 24, 2021

Ventus Therapeutics to Present Data for Novel Peripherally Restricted and Brain-Penetrant NLRP3 Small Molecule Inhibitors for the Treatment of Inflammatory and Neurological Diseases

Sep 22, 2021

Hexagon Bio Raises $61 Million to Advance Novel Small-Molecule Medicines Mined from Microbial Genomes

Sep 22, 2021

Model Medicines announces preclinical data in study of orally available lead therapeutic (MDL-001) against COVID-19, in partnership with Scripps Research and Mount Sinai, demonstrating efficacy against primary endpoint

Sep 21, 2021

HemoShear Therapeutics Advancing Several Novel Compounds for Horizon Therapeutics plc Gout Discovery Pipeline

Sep 21, 2021

858 Therapeutics Launches with Proven Team and $60 Million Series A Financing

Sep 21, 2021

Black Diamond Therapeutics and OpenEye Scientific Announce Collaboration to Expand MAP Drug Discovery Platform

Aug 5, 2021

Bayer Strengthens Drug Discovery Platform Through Acquisition of Vividion Therapeutics

Aug 4, 2021

Exscientia Builds Automated Laboratories in Oxford to Expand Pipeline

Jul 29, 2021

Quell Therapeutics Appoints Tracey Lodie, Ph.D., as Chief Scientific Officer

Jul 28, 2021

Complix Signs Global Drug Discovery and Development Agreement with Jiangsu Nhwa Pharmaceutical Co. to Develop Novel Alphabody Therapeutics for Treatment of CNS Diseases

Jul 27, 2021

Goldfinch Bio Announces Upcoming Presentations at the 13th International Podocyte Conference

Jul 21, 2021

Exscientia and GT Apeiron Therapeutics Enter Oncology Joint Venture

Jul 9, 2021

Muna Therapeutics Launches with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases

Jul 8, 2021

Exscientia Accelerates COVID-19 Drug Discovery Using AI

Jul 8, 2021

Xilis Raises $70 Million Series A Financing to Advance Diagnostic and Drug Discovery and Development Platform Leveraging Proprietary MicroOrganoSphere™ Technology

Jun 24, 2021

Anavo Therapeutics Strengthens Scientific Advisory Board with Industry-Leading Drug Discovery Experts in Oncology

Jun 24, 2021

EQRx and Exscientia Enter Strategic Drug Creation, Development, and Commercialization Collaboration to Accelerate the Advancement of New World-Class Medicines

Jun 14, 2021

Expansion Therapeutics Names Mark Ledeboer, Ph.D., Senior Vice President of Drug Discovery

May 19, 2021

Exscientia announces multi-target, AI-driven drug discovery collaboration with Bristol Myers Squibb

May 17, 2021

PrecisionLife and Cyclica Sign Strategic Partnership Combining Leading Data-driven Biology and Chemistry Platforms to Create a Rapid Innovation Engine for Drug Discovery

May 13, 2021

Flare Therapeutics Launches with $82 Million Series A Financing to Advance Precision Oncology Pipeline based on Novel Drug Discovery Approach for Transcription Factors

May 11, 2021

STALICLA Appoints Baltazar Gomez-Mancilla, MD, PhD, as Chief Medical Officer

May 6, 2021

Volastra Therapeutics Extends Seed Financing to $44 Million to Advance Drug Discovery Programs to Prevent Cancer Metastasis

May 5, 2021

HitGen and BioAge Announce Research Progress in DNA-Encoded Library Based Drug Discovery Research Collaboration

May 5, 2021

Eikon Therapeutics Closes $148 Million Series A Financing to Develop High-Throughput, Super-Resolution Microscopy for Drug Discovery

May 4, 2021

twoXAR Pharmaceuticals Rebrands as Aria Pharmaceuticals, Provides Pipeline Update and Announces New Therapeutic Development Strategy

Apr 27, 2021

Exscientia Announces Investment of up to $525M

Apr 21, 2021

HemoShear Therapeutics Advances Second Novel Drug Target into Horizon Therapeutics plc Early Discovery Pipeline for Gout

Apr 15, 2021

Alchemab to Collaborate With AstraZeneca to Use Alchemab’s Drug Discovery Platform for Prostate Cancer Study

Apr 14, 2021

Cyclica Teams Up with Top-Tier Academic Institutions to Identify a Repurposed COVID Drug

Mar 23, 2021

Model Medicines announces AI-driven drug discovery partnership with Sanford Burnham Prebys

Mar 15, 2021

insitro Raises $400 Million in Series C Financing

Mar 10, 2021

Complix Signs Global Drug Discovery and Development Agreement with I-Mab to Develop Cell Penetrating Alphabodies against Two Intracellular Immuno-oncology Targets

Mar 9, 2021

Asceneuron Receives USD 2.2 Million Award from the Alzheimer's Drug Discovery Foundation

Mar 9, 2021

Atomwise Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2021

Mar 4, 2021

Exscientia Completes $100 million Series C Financing Round With BlackRock Funds

Feb 28, 2021

HitGen and UPPTHERA Enter Into Drug Discovery Research Collaboration

Feb 26, 2021

Roivant Grows Computational Drug Discovery Engine with Acquisition of Silicon Therapeutics

Feb 18, 2021

Eurofins Scientific Announces Acquisition of Beacon Discovery, Substantially Expanding Its Integrated Drug Discovery Capabilities and Expertise

Feb 8, 2021

Monte Rosa Therapeutics Expands Senior Management Team

Jan 19, 2021

AbCellera Granted U.S. Patent Covering its Trianni Mouse Technology

Jan 11, 2021

Eleusis Accelerates Psychedelic Drug Discovery and Development Team with Appointment of David Nichols, Ph.D., as Director of Molecular Pharmacology

Jan 7, 2021

Werewolf Therapeutics Completes $72 Million Series B Financing to Advance a Novel Class of Cancer Biotherapeutics to the Clinic

Dec 10, 2020

HemoShear Therapeutics Identifies Novel Drug Target to Treat NASH in Drug Discovery Partnership with Takeda

Dec 10, 2020

Evommune and Axcelead Drug Discovery Partners Launch A Collaboration On A PKC[theta] Program To Kick-off Evommune's Inflammation Pipeline

Dec 8, 2020

Anima Biotech to Participate in the 3rd Annual RNA-Targeted Drug Discovery Conference

Dec 2, 2020

Genesis Therapeutics Secures $52M Series A to Further Accelerate AI Innovation and to Launch Drug Discovery and Development Pipeline

Dec 1, 2020

Casma Therapeutics and Vipergen Enter Into Drug Discovery Agreement

Nov 30, 2020

Cedilla and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery

Nov 18, 2020

AbCellera Expands Technology Stack with Acquisition of Trianni for $90 Million

Nov 5, 2020

Cellarity signs up with Excelra for GOSTAR database to enrich its drug discovery platform English English English Deutsch

Nov 5, 2020

Cellarity signs up with Excelra for GOSTAR database to enrich its drug discovery platform English English Deutsch

Nov 5, 2020

Cellarity signs up with Excelra for GOSTAR database to enrich its drug discovery platform USA - English USA - English Deutschland - Deutsch

Nov 5, 2020

Cellarity signs up with Excelra for GOSTAR database to enrich its drug discovery platform India - English India - English USA - Deutsch

Oct 27, 2020

Lodo Therapeutics Achieves Second Preclinical Milestone In Its Strategic Collaboration With Genentech

Oct 22, 2020

insitro Strengthens Machine Learning-Based Drug Discovery Capabilities with Acquisition of Haystack Sciences

Oct 20, 2020

Renew Biopharma Announces New Executive Leadership to Drive its Drug Discovery Program

Oct 19, 2020

Genesis Therapeutics Enters AI-driven, Multi-Target Drug Discovery Partnership with Genentech

Oct 12, 2020

HitGen to Acquire Vernalis, a Leader in Structure-Based Drug Discovery

Sep 23, 2020

Celmatix Achieves Second Milestone in Women’s Health Drug Discovery Alliance with Evotec

Sep 23, 2020

Escient Pharmaceuticals Appoints Veena Viswanath, Ph.D., as VP of Translational Biology and Drug Discovery

Sep 23, 2020

Systems Oncology, an AI-based Cancer Therapy Discovery and Development Company, Is Honored With a 2020 AZBio Fast Lane Award

Sep 9, 2020

Bayer Collaborates with Recursion to Strengthen Digital Drug Discovery and Advance New Therapies for Fibrotic Diseases

Sep 3, 2020

Lodo Therapeutics Acquires Hibiskus BioPharma And Licenses Rights To Novel Proteasome Inhibitors

Aug 26, 2020

HiFiBiO Therapeutics Submits IND Application for Fully Human SARS-CoV-2 Neutralizing Antibody for the Treatment of COVID-19 Patients

Aug 19, 2020

ROME Therapeutics Appoints Drug Discovery Veteran Dennis Zaller, Ph.D., as Chief Scientific Officer

Aug 17, 2020

HiFiBiO Therapeutics Collaborates with Coronavirus Immunotherapy Consortium in the Fight Against COVID-19

Aug 11, 2020

Atomwise Raises $123 Million in Series B Financing Co-Led by B Capital Group and Sanabil

Aug 4, 2020

Recursion Posts Immune Mapping and Drug Discovery Resource and Releases New Image Datasets

Jul 28, 2020

Recursion Acquires Vium Bolstering Its Efforts to Industrialize Drug Discovery

Jul 9, 2020

HemoShear Therapeutics Achieves Milestone in Exclusive Drug Discovery Collaboration with Horizon Therapeutics in Gout

Jul 5, 2020

HitGen and Morphic Extend Drug Discovery Research Collaboration

Jun 29, 2020

European AI in Drug Discovery Market Outlook 2020-2026 with Profiles of Key Players Including Atomwise, Deep Genomics, Google, IBM, Insilico Medicine, and Verge Genomics Amongst Others - ResearchAndMarkets.com

Jun 22, 2020

Ribon Therapeutics Presents Additional Preclinical Data on its PARP7 Inhibitor – RBN-2397 – and Demonstrates Broad Potential of its Platform at the AACR 2020 Virtual Meeting II

Jun 17, 2020

BERG Creates New Drug Research Effort to Use Oak Ridge National Laboratory's Summit Supercomputer in the Fight Against COVID-19

Jun 16, 2020

Kronos Bio Expands Leadership Team With Appointment of Seasoned Drug Discovery Leader Christopher Dinsmore, Ph.D., as Chief Scientific Officer

Jun 8, 2020

Nimbus Therapeutics Announces Expansion of Its Drug Discovery Pipeline Across Oncology, Immunology and Metabolism

Jun 7, 2020

HitGen and Evotec SE Enter Into Drug Discovery Research Collaboration

Jun 3, 2020

Celmatix Achieves First Milestone in Women’s Health Drug Discovery Alliance With Evotec

Jun 3, 2020

Insights into the Worldwide Artificial Intelligence in Drug Discovery Industry to 2026 - Featuring Atomwise, BenevolentAI and Berg Among Others - ResearchAndMarkets.com

Jun 1, 2020

Michael White, Ph.D. joins Samumed as Chief Scientific Officer

May 27, 2020

MiNA Therapeutics Announces Publication of Phase I Liver Cancer Data in Clinical Cancer Research and Provides Update on Clinical Development and Drug Discovery Programs

May 27, 2020

AbCellera Closes $105 Million Series B Financing to Further Advance World-Leading Antibody Drug Discovery Platform

May 26, 2020

insitro Announces $143 Million Raised in Series B Financing

May 25, 2020

Oncodesign and HitGen Announce a Strategic Partnership in Integrated Drug Discovery Services (IDDS)

May 22, 2020

AbCellera Announces Multi-Year Antibody Discovery Collaboration with Lilly

May 19, 2020

Vividion Therapeutics Announces Drug Discovery Collaboration with Roche Focused on Novel E3 Ligases

May 19, 2020

2020 Insights into AI for Drug Discovery in the Pharmaceutical Industry - Featuring Acurastem, Atomwise and Biovista Among Others - ResearchAndMarkets.com

May 8, 2020

Arrakis Therapeutics Enters Strategic Collaboration and License Agreement with Roche for Multi-Target Program Utilizing RNA-Targeted Small Molecule Drug Discovery Platform

May 5, 2020

SRI International and Exscientia Enter Collaboration to Accelerate Drug Discovery Through Automation and Artificial Intelligence

May 3, 2020

AbCellera Receives $175.6 Million from the Government of Canada to Discover Solutions for COVID-19 and Build a Manufacturing Facility for Antibody Drugs

Apr 24, 2020

Recursion Releases First Open-Source Morphological Imaging Dataset on SARS-CoV-2 Virus

Apr 14, 2020

Cyclica Forms Multi-Year and Multi-Project Drug Discovery Partnership with the Genome Institute of Singapore

Apr 13, 2020

BERG Named Visionary in Frost and Sullivan's First-Ever Frost Radar™ AI in Drug Discovery Report in the Pharmaceutical Industry

Apr 6, 2020

Gilead Sciences and Second Genome Announce Strategic Collaboration in Biomarker and Inflammatory Bowel Disease Drug Discovery

Mar 26, 2020

OneThree Biotech Announces $2.5M Seed Funding and Free Toxicity Screening for Small Molecules Treating COVID-19

Mar 3, 2020

twoXAR Pharmaceuticals Announces Appointment of Mark Eller, Ph.D. as Senior Vice President of Research and Development and Anjali Pandey, Ph.D. as Senior Vice President of Nonclinical RandD and Chemistry

Feb 25, 2020

1ST Biotherapeutics and twoXAR Advance Three Novel Glioblastoma Treatment Candidates into In Vivo Testing in Less Than One Year

Feb 11, 2020

Vividion Therapeutics Appoints Drug Discovery and Development Expert, Robert Abraham, Ph.D., as Chief Scientific Officer

Feb 5, 2020

Arrakis Therapeutics Appoints Jacques Dumas, Ph.D., as Senior Vice President, Drug Discovery

Jan 14, 2020

HitGen Enters into DNA-Encoded Library Based Drug Discovery Research Collaboration with Kymera

Jan 9, 2020

Evotec and Bayer Announce New Alliance Focusing on Drug Discovery for Polycystic Ovary Syndrome With Novel Targets From Celmatix

Jan 7, 2020

PhoreMost and Boehringer Ingelheim enter multi-project drug discovery collaboration

Dec 10, 2019

Flagship Pioneering Unveils Cellarity, the First Company to Discover Medicines Targeting Cell Behavior

Dec 9, 2019

Healx Joins Forces with Boehringer Ingelheim to Discover New Treatment Approaches for Rare Neurological Diseases

Dec 2, 2019

Anima Biotech to Present at the 2nd Annual RNA-Targeted Drug Discovery Summit

Oct 28, 2019

Eurofins Discovery Announces Collaboration with Escient Pharmaceuticals

Oct 28, 2019

Prelude Therapeutics expands in Delaware; Adding biotech jobs in cancer drug discovery research

Oct 24, 2019

Oblique Therapeutics Will be Presenting at the Inaugural RAS- Targeted Drug Discovery Europe Summit in Vienna in February 2020

Oct 18, 2019

LifeMine Therapeutics Powers Drug Discovery Team to Search the Biosphere for Nature's Evolved Solutions to Intractable Therapeutic Challenges

Oct 16, 2019

HitGen Enters into DNA-Encoded Library Based Drug Discovery Research Collaboration with Galapagos NV

Oct 2, 2019

SEngine Precision Medicine Raises $5.1 Million Series A to Advance Personalized Oncology Drug Discovery Platform

Sep 27, 2019

Ribometrix Announces $7.8 Million in New Funding to Advance RNA-Targeting Drug Discovery Platform

Sep 19, 2019

Black Diamond Therapeutics Names Christopher Roberts, Ph.D., as Chief Scientific Officer

Sep 11, 2019

AgeneBio Announces Additional Funding to Advance Novel GABA-A Therapeutic Program to Address Alzheimer's and Other CNS Conditions

Sep 11, 2019

Hansoh Pharma and Atomwise Launch Strategic AI Drug Discovery Collaboration for Multiple Therapeutic Areas

Sep 11, 2019

Atomwise Announces Largest China-US Collaboration for AI Drug Discovery

Sep 10, 2019

Cognition Therapeutics’ Founder/CSO to Provide Update on Elayta™ Clinical Progress at ADDF Alzheimer’s Drug Discovery Conference

Sep 10, 2019

SEngine Precision Medicine and Atomwise Announce Strategic Joint Venture to Accelerate Novel Drug Discovery

Sep 3, 2019

Cybrexa Therapeutics Announces Appointment of Biotech Industry Leader John Houston to Board of Directors

Aug 13, 2019

Schrödinger Expands Drug Discovery Partnership with Morphic Therapeutic

Jul 17, 2019

Gotham Therapeutics and Mercachem Announce Progress in Compound Library Development Tailored for Epitranscriptomic Drug Discovery

Jul 11, 2019

Dr Neil Thompson Appointed Chief Scientific Officer of Healx to Spearhead Drug Discovery Expansion

Jul 10, 2019

Research Collaboration Between U-M and Atomwise to Accelerate Drug Discovery Using Innovative Artificial Intelligence Approach

Jun 19, 2019

Gilead and Nurix Establish Strategic Collaboration to Develop Novel Therapies for Cancer and Other Diseases

Jun 19, 2019

Gilead and Nurix Establish Strategic Collaboration to Develop Novel Therapies for Cancer and Other Diseases

Jun 12, 2019

Harbour BioMed and Erasmus MC Sign MoU to Advance Next-Generation Immuno-oncology, and Immunology Drug Discovery and Clinical Development

Jun 3, 2019

Cerevance Appoints CNS Drug Developer James Summers, Ph.D. as Scientific Advisor

Jun 3, 2019

HitGen Enters into DNA-Encoded Library Based Drug Discovery Research Collaboration with Gilead Sciences

Jun 3, 2019

Atomwise Announces Multi-year, Multi-target Agreement with Lilly for AI-Driven Drug Discovery Program

May 21, 2019

Gotham Therapeutics and ZoBio Achieve Significant Milestone in Epitranscriptomic Drug Discovery Collaboration

May 8, 2019

Gilead Sciences and Goldfinch Bio Announce Strategic Collaboration to Develop Novel Therapies for Kidney Disease

May 6, 2019

Recursion Releases Open-Source Data from Largest Ever Dataset of Biological Images, Inviting Data Science Community to Develop New and Improved Machine Learning Algorithms for the Life Sciences Industry

Apr 16, 2019

RNA Therapeutics Startup Panorama Medicine Raises $3.7 Million to Accelerate Drug Discovery Using Genomics and Artificial Intelligence

Apr 16, 2019

Cerevance Appoints Industry Veteran as Vice President of Drug Discovery

Mar 25, 2019

HitGen and Almirall Enter DNA-Encoded Library Based Innovative Drug Discovery Research Collaboration

Mar 20, 2019

Takeda and HemoShear Therapeutics Extend Exclusive Drug Discovery Partnership in Liver Diseases

Mar 18, 2019

Ono Pharmaceutical and twoXAR Announce Drug Discovery Research Collaboration

Mar 12, 2019

HitGen and SPARC Enter DNA-Encoded Library Based Innovative Drug Discovery Research Collaboration

Feb 28, 2019

VenatoRx Pharmaceuticals Awarded NIAID R01 Grant to Uncover Determinants of Gram-Negative Permeability

Jan 23, 2019

Philogen Announces Drug Discovery Collaboration With Johnson & Johnson Innovation

Jan 23, 2019

Philogen Announces Drug Discovery Collaboration With Johnson and Johnson Innovation

Jan 11, 2019

Atomwise and Charles River Laboratories Form a Strategic Alliance to Provide Premier Artificial Intelligence-Powered Drug Discovery Capabilities

Jan 11, 2019

Charles River Laboratories and Atomwise Form a Strategic Alliance to Provide Integrated, Artificial Intelligence-Driven Drug Discovery

Jan 7, 2019

Numerate and Lundbeck Partner to Apply AI Drug Discovery to Unlock Challenges of Neuroscience Research

Jan 7, 2019

Recursion Announces Options Exercise by Takeda and Extension of AI-enabled Drug Discovery Collaboration

Jan 3, 2019

Horizon Pharma plc and HemoShear Therapeutics Enter into Exclusive Drug Discovery Collaboration in Gout

Jan 2, 2019

Propanc Biopharma Commences Drug Discovery Research Collaboration

Dec 20, 2018

Jnana Therapeutics Expands Board of Directors and Forms Scientific Advisory Board

Dec 18, 2018

Kymera Therapeutics Announces Expansion of Scientific Advisory Board to Advance Pre-Clinical Molecules Toward the Clinic

Dec 10, 2018

HitGen and Mitsubishi Tanabe Pharma Enter DNA-Encoded Library Based Innovative Drug Discovery Research Collaboration

Dec 3, 2018

HitGen Enters into DNA-Encoded Library Based Drug Discovery Research Collaboration with Genentech

Nov 28, 2018

twoXAR Receives $225K Phase I SBIR Grant for Pancreatic Cancer Drug Discovery

Nov 26, 2018

Cyclica Drives Drug Discovery Through AI-Augmented Integrated Network of Cloud-Based Technologies together with Bayer

Nov 21, 2018

HitGen and Biogen enter a DNA-Encoded Library-Based Drug Discovery Research Collaboration

Oct 23, 2018

Arcellx Presents Preclinical Data for ARC-sparX Platform Technology in Targeting CD123-Positive AML Tumors

Oct 16, 2018

REVOLUTION Medicines Acquires Warp Drive Bio to Expand Drug Discovery Portfolio Focused on Frontier Oncology Targets

Oct 9, 2018

Neurocrine Biosciences and Jnana Therapeutics Enter Strategic Collaboration to Discover Novel Medicines to Treat Central Nervous System Disorders

Oct 4, 2018

Axcelead Drug Discovery Partners and ERS Genomics Enter into CRISPR/Cas9 License Agreement

Oct 1, 2018

Renew Biopharma CEO Michael Mendez to Speak at SynBioBeta 2018

Sep 26, 2018

Second Genome Appoints Karim Dabbagh, Ph.D., as Chief Executive Officer

Aug 16, 2018

WuXi AppTec Research Service Division and Cyclica Collaborate to Drive Polypharmacology in Drug Discovery Through AI-Augmented Technologies

Jul 30, 2018

IFM Therapeutics Announces New Publication in Nature Reviews Drug Discovery Examining NLRP3 as a Target in Serious Inflammatory and Immune-Mediated Diseases

Jul 17, 2018

HotSpot Therapeutics Completes $45 Million Series A Financing to Advance New Approach to Allosteric Drug Discovery

Jul 16, 2018

Verge Genomics Announces $32 Million Series A to Lead Artificial Intelligence-Driven Drug Discovery

Jul 11, 2018

Perlara announces n=1 drug discovery pact with Mission: Cure

Jun 28, 2018

Cedilla Therapeutics Expands Leadership Team with New Appointments to Direct Biology, Drug Discovery and Proteomics

May 31, 2018

Bicycle Therapeutics Announces Formation of Scientific Advisory Board

May 31, 2018

Harbour BioMed Announces Multi-Year Transgenic Platform Licensing Agreement with Celsius Therapeutics for Fully Human Monoclonal Antibody Drug Discovery

May 22, 2018

Alzheon to Make Presentations at Upcoming Industry and Investor Conferences

May 16, 2018

FogPharma Secures $66 Million Series B Financing

May 9, 2018

FORMA Therapeutics and the University of Oxford Announce Multi-Year Collaboration to Advance the Development of Deubiquitinating Enzyme (DUB) Inhibitors for the Treatment of Neurodegenerative Diseases

May 9, 2018

Lodo Therapeutics Corporation Forms Multi-Target Strategic Collaboration with Genentech

May 8, 2018

XtalPi Inc. Announces Strategic Research Collaboration with Pfizer Inc. to Develop Artificial Intelligence-Powered Molecular Modeling Technology for Drug Discovery

May 7, 2018

Recursion Pharmaceuticals Receives Grant to Leverage AI-Enabled Discovery Platform in Infectious Disease

Feb 27, 2018

Beacon Discovery announces multi-year GPCR drug discovery collaboration with Takeda focused on gastrointestinal disorders

Feb 12, 2018

Sirenas Enters Into Multi-Target Collaboration With Bristol-Myers Squibb

Jan 23, 2018

AI Biotech XtalPi Closes Series B Round Funding from Sequoia China, Google, and Tencent

Jan 8, 2018

Renew Biopharma Launches Pre-Clinical Drug Discovery Program with Indiana University Bloomington’s Gill Center for Biomolecular Science Using Cannabinoids Grown in Microalgae

Jan 7, 2018

Harbour BioMed Announces Multi-Year Transgenic Platform Licensing Agreement with BeiGene for Fully Human Monoclonal Antibody Drug Discovery

Jan 4, 2018

Beacon Discovery announces multi-year GPCR-focused drug discovery collaboration with Janssen Pharmaceuticals

Dec 19, 2017

Confo Therapeutics Enters Into Drug Discovery Collaboration with Roche

Dec 13, 2017

Sirenas Receives Research Grant Totaling $1.68 M To Accelerate Its Drug Discovery Technology, ATLANTIS™

Nov 30, 2017

Cyclica Launches Ligand Express™, a Disruptive Cloud-Based Platform to Revolutionize Drug Discovery

Nov 27, 2017

HITGEN and Boehringer Ingelheim Enter DNA-Encoded Library Based Drug Discovery Research Collaboration

Oct 30, 2017

Kymera Therapeutics Announces Series A to Advance Novel Therapeutic Modality and Develop Innovative Therapies

Oct 17, 2017

Takeda and HemoShear Therapeutics Enter into Exclusive Drug Discovery Partnership in Liver Diseases

Oct 12, 2017

Harbour BioMed Announces Multi-Year Transgenic Platform Licensing Agreement with Innovent Biologics, Inc. for Fully Human Monoclonal Antibody Drug Discovery

Oct 2, 2017

Mission Therapeutics’ Scientists Highlight Significance of Deubiquitylating Enzymes (DUBs) as Key Drug Targets

Oct 2, 2017

KSQ Therapeutics Emerges with $76 Million in Financing to Pioneer High-Confidence Drug Development

Sep 28, 2017

Evotec Invests in Exscientia to Advance AI-Driven Drug Discovery

Sep 11, 2017

HitGen and Takeda Enter DNA-Encoded Library Based Drug Discovery Research Collaboration

Jul 1, 2017

Exscientia Enters Strategic Drug Discovery Collaboration with GSK

Jun 30, 2017

AgeneBio Receives Grant from Alzheimer's Drug Discovery Foundation for Drug-Discovery Program to Delay the Onset of Alzheimer's Dementia

Jun 19, 2017

twoXAR Announces Preclinical Proof-of-Concept Data on Type 2 Diabetes Candidate

Jun 12, 2017

Numerate and Takeda Enter Agreement to Generate Novel Clinical Candidates Using AI-Driven Drug Discovery

May 24, 2017

HitGen Announces Drug Discovery Collaboration with the Scripps Research Institute and the California Institute for Biomedical Research (Calibr)

May 13, 2017

Funding From Alzheimer’s Drug Discovery Foundation Advances M3 Biotechnology Toward Human Trials

Apr 18, 2017

Dr. Yolanda Chong Joins Recursion Pharmaceuticals to Advance Discovery Platform

Feb 27, 2017

Arrakis Therapeutics Announces $38 Million Series A Financing to Target RNA with Small-Molecule Medicines and Names Michael Gilman Chairman and CEO

Dec 21, 2016

Recursion Receives Industry Awards for Drug Discovery Platform

Dec 9, 2016

Forge Therapeutics and Evotec Form Strategic 'Superbug' Alliance

Dec 9, 2016

Evotec and Forge Therapeutics Form Strategic 'Superbug' Alliance

Nov 22, 2016

Recursion Raises Additional Funding, Bringing Total Series A to $15.05M for Drug Discovery

Oct 31, 2016

Pioneering Drug Discovery Company Bridge Medicines Launched to Advance Promising Early Technologies in Major Academic Institutions through Human Proof of Concept

Oct 26, 2016

Recursion Pharmaceuticals Selects Anaconda to Create Innovative Next Generation Drug Discovery Assay Platform to Eradicate Rare Genetic Diseases

Oct 18, 2016

Sirenas and Calibr to Form Drug Discovery Collaboration

Oct 3, 2016

Recursion Pharmaceuticals Raises $13M to Discover New Drugs Using Artificial Intelligence

Sep 29, 2016

Sirenas Awarded Grant to Identify Nature-Inspired Drug Leads for Neglected Diseases

Jun 14, 2016

twoXAR Completes Initial Studies of New Rheumatoid Arthritis Drug Candidates

May 5, 2016

FLX Bio Completes Leadership Team in Immuno-Oncology Drug Discovery

Mar 28, 2016

Forge Therapeutics and Active Motif to Collaborate on Epigenetic Research and Drug Discovery

Feb 16, 2016

Carmot Therapeutics Extends Drug Discovery Collaboration with Amgen

Feb 10, 2016

Yumanity Therapeutics Closes $45 Million Series A Financing

Feb 8, 2016

FLX Bio Hires Senior Leaders in Immuno-Oncology Drug Discovery

Jan 7, 2016

C4 Therapeutics Enters Strategic Drug Discovery Collaboration in the Promising New Field of Targeted Protein Degradation

Jun 24, 2015

twoXAR Accelerates Digital Assault on Drug Discovery With Support From Stanford-Backed StartX Med Program

Feb 26, 2015

CORRECTING and REPLACING Recursion Pharmaceuticals Wins $1.5M NIH Grant for Rare Disease Drug Discovery

Jan 28, 2015

AgeneBio Receives Grant from Alzheimer's Drug Discovery Foundation for New Approach to Delaying the Onset of Alzheimer's Dementia

Jan 7, 2015

Caribou Biosciences Announces New Research Collaboration and Equity Investment Agreements with Novartis

Dec 2, 2014

Nurix Launches Collaboration with Mount Sinai Hospital’s Lunenfeld-Tanenbaum Research Institute to Expand its Drug Discovery Program

Nov 20, 2014

Navitor Pharmaceuticals Appoints Eddine Saiah, PhD, as Vice President of Drug Discovery

Oct 28, 2014

Raze Therapeutics Appoints Mikel Moyer, PhD, as Vice President, Molecular Discovery

Oct 7, 2014

Second Genome and Mayo Clinic Enter Collaboration to Develop Microbiome Therapeutics in Multiple Diseases

Jun 19, 2014

Navitor Pharmaceuticals Launches with $23.5 Million Series A Financing for Novel Drug Discovery Targeting Cellular Nutrient Signaling to Treat Chronic Diseases and Rare Disorders

Jun 3, 2014

Asana BioSciences, LLC, an Amneal Alliance Company, Acquires Branded Drug Discovery Platform from Endo International plc

May 30, 2014

Professor Bud Mishra, PhD Joins the Science Advisory Board of InSilico Medicine Engaged in Aging Research for Drug Discovery

Apr 28, 2014

University Of Miami Miller School Of Medicine Partners With Boston Biotech Firm Berg To Fuel The Next Generation Of Drug Discovery

Mar 5, 2014

Hawaii Biotech Adds Drug Discovery To Vaccine Development

Feb 28, 2014

Abide Therapeutics Announces Strategic Drug Discovery Collaboration with Celgene Corporation to Advance Treatment Paradigm for Patients with Immune Disorders

Feb 25, 2014

PMV Pharma and Chiromics Announce Licensing Agreement and Drug Discovery Collaboration

Jan 14, 2014

Carmot Therapeutics Enters into Drug Discovery Collaboration with Amgen

Oct 29, 2013

Abide Therapeutics Appoints Dr. Gary O'Neill as Vice President of Biology

Oct 10, 2013

Berg and Icahn School of Medicine at Mount Sinai Announce R&D Partnership for Drug Discovery and Development

Sep 11, 2013

Berg Receives Frost and Sullivan 2013 Drug Discovery Technology Innovation Award

Jun 18, 2013

FORMA Therapeutics Launches New Collaborative Framework to Transform Basic Research into Promising Therapies

Jun 5, 2013

Second Genome Announces Agreement with Janssen on Microbiome Drug Discovery in Ulcerative Colitis

Dec 10, 2012

Bicycle Therapeutics Announces £3.75 Million Financing for Drug Discovery

Mar 14, 2012

Numerate Forms Drug Discovery Collaboration with Merck to Utilize Numerate’s In Silico Drug Design Technology

Jan 10, 2012

FORMA Therapeutics Announces an Exclusive Cancer Drug Discovery Alliance Focused on Tumor Metabolism with Janssen Biotech, Inc.

Dec 6, 2011

Numerate and Boehringer Ingelheim (Canada) Form Research Collaboration Based on in silico Drug Design Technology

Sep 8, 2011

Sucampo and Numab Sign Drug Discovery Collaboration

Nov 16, 2010

Eisai and FORMA Therapeutics Enter into Broad Drug Discovery Collaboration

Aug 26, 2010

Alzheimer's Drug Discovery Foundation Funds AgeneBio to Advance Pharmacological Neural Stabilizer Technology

Aug 18, 2010

Alzheimer's Drug Discovery Foundation Funds Cognition Therapeutics to Advance Disease-Modifying Small Molecule Drug Candidates for Alzheimer's Disease

Mar 15, 2010

The Leukemia & Lymphoma Society and FORMA Therapeutics Enter a Drug Discovery Alliance to Discover and Develop Novel Therapies For Patients with Diffuse Large B Cell Lymphoma